Serum soluble Fas level as a prognostic factor in patients with gynecological malignancies

Medicine & Life Sciences

• Carcinoma 100%
• Serum 80%
• Endometrial Neoplasms 77%
• Neoplasms 56%
• Apoptosis 30%
• Fas Ligand Protein 30%
• Survival 27%
• Alternative Splicing 27%
• Natural Killer Cells 23%
• Uterine Cervical Neoplasms 23%
• Proportional Hazards Models 22%
• Carcinogenesis 19%
• Survival Rate 18%
• Enzyme-Linked Immunosorbent Assay 17%
• Radiotherapy 17%
• Drug Therapy 14%
• Messenger RNA 14%